Tumor-associated neutrophils contribute to neovascularization by supplying
matrix metalloproteinase-9 (MMP-9), a
protease that has been genetically and biochemically linked to induction of angiogenesis. Specific roles of inflammatory neutrophils and their distinct
proMMP-9 in the coordinate regulation of
tumor angiogenesis and
tumor cell dissemination, however, have not been addressed. We demonstrate that the primary
tumors formed by highly disseminating variants of human
fibrosarcoma and prostate
carcinoma recruit elevated levels of infiltrating MMP-9-positive neutrophils and concomitantly exhibit enhanced levels of angiogenesis and intravasation. Specific inhibition of neutrophil influx by
interleukin 8 (IL-8) neutralization resulted in the coordinated diminishment of
tumor angiogenesis and intravasation, both of which were rescued by purified neutrophil
proMMP-9. However, if neutrophil
proMMP-9, naturally devoid of
tissue inhibitor of metalloproteinases (TIMP), was delivered in complex with
TIMP-1 or in a mixture with
TIMP-2, the
protease failed to rescue the inhibitory effects of anti-IL8
therapy, indicating that the TIMP-free status of
proMMP-9 is critical for facilitating
tumor angiogenesis and intravasation. Our findings directly link
tumor-associated neutrophils and their TIMP-free
proMMP-9 with the ability of aggressive
tumor cells to induce the formation of new blood vessels that serve as conduits for
tumor cell dissemination. Thus, treatment of
cancers associated with neutrophil infiltration may benefit from specific targeting of neutrophil MMP-9 at early stages to prevent ensuing
tumor angiogenesis and
tumor metastasis.